Skip to content

Effect of anisodamine hydrobromide on microcirculation in patients with septic shock: a multicenter prospective real-world study

Effect of anisodamine hydrobromide on microcirculation in patients with septic shock: a multicenter prospective real-world study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125716
Enrollment
Unknown
Registered
2026-05-29
Start date
2026-05-31
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic shock

Interventions

Exposed group:Anisodamine hydrobromide injection was used
Non-exposed group:Anisodamine hydrobromide injection had not been used

Sponsors

The Third Affiliated Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >=18 years old; 2.Meet the diagnostic criteria for septic shock (sepsis 3.0); 3.Within 48 hours of diagnosis of septic shock; 4.Sublingual microcirculation data could be monitored by handheld microcirculation imager during the study period; 5.Informed consent was obtained from patients or their legal representatives;

Exclusion criteria

Exclusion criteria: 1.Combined with other causes of shock (such as cardiogenic shock, hemorrhagic shock); 2.Patients treated with anisodamine within 48 hours before screening; 3.Predicted survival time <48 hours (such as end-stage disease, irreversible multiple organ failure); 4.Pregnant or lactating women; 5.Participating in other interventional clinical trials; 6.Patients whose sublingual microcirculation could not be measured; 7.Not suitable to participate in the study according to the investigator's judgment.

Design outcomes

Primary

MeasureTime frame
Microcirculatory Flow Index?(MFI);

Secondary

MeasureTime frame
Improvement rate of microcirculation;28 All-cause mortality rate;PVD (Perfusion Vessel Density);? POEM score: The differences between the measured values at 24h, 48h, 72h, and 96h after enrollment and the baseline values;The proportion and duration of mechanical ventilation and renal replacement therapy within 28 days;Total dose (in terms of methoxamine equivalent) of vasoactive drugs used within 28 days;The differences between the measured values at 24 hours, 48 hours, 72 hours and 96 hours after enrollment and the baseline values.;Capillary refill time (CRT);PPV(Perfused Vessel Proportion);Liquid net balance volume;TVD (Total Vascular Density);The number of days during which vasoconstrictor drugs were used within 28 days;POEM score;Blood lactate clearance rate;

Countries

China

Contacts

Public ContactHong Yang

The Third Affiliated Hospital of Southern Medical University

yhicu_1103@163.com+86 20 6278 4503

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026